CS 104
Alternative Names: CS-104Latest Information Update: 25 Jan 2024
At a glance
- Originator CorrectSequence Therapeutics
- Class Gene therapies
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 17 Jan 2024 Preclinical trials in Unspecified in China (Parenteral) before January 2024 (CorrectSequence Therapeutics pipeline, January 2024)